Building better bacteria

Researchers from the J. Craig Venter Institute have developed a technique for generating modified strains of bacteria with novel, genetically engineered properties, they report online today (August 20) in Science. The advance could help scientists tweak microorganisms to more efficiently produce biofuels, the researchers say. Modified M. Mycoides Image: The J. Craig Venter Institute "I think it's an important and interesting advance," said linkurl:James Collins,;http://www.bu.edu/abl/ a bioen

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
Researchers from the J. Craig Venter Institute have developed a technique for generating modified strains of bacteria with novel, genetically engineered properties, they report online today (August 20) in Science. The advance could help scientists tweak microorganisms to more efficiently produce biofuels, the researchers say.
Modified M. Mycoides
Image: The J. Craig Venter Institute
"I think it's an important and interesting advance," said linkurl:James Collins,;http://www.bu.edu/abl/ a bioengineer at Boston University who was not involved in the study. "I suspect this will turn out to be quite important for bioengineering and bioenergy systems." Last year, Venter, an author on the paper (and a member of The Scientist's editorial board), linkurl:reported;http://www.the-scientist.com/blog/display/54212/ that he and his collaborators had created a synthetic bacterial genome and cloned it into a yeast cell. However, they were unable to transfer the genome into a cell that would use the genetic code to produce a functioning version of the organism. In the current paper, the researchers present a technique for doing just that. The Venter team first cloned the genome of the bacterium Mycoplasma mycoides into a yeast cell. They then altered the genome, using the myriad tools available for yeast gene manipulation. In the procedure's trickiest step, they transplanted the yeast-bound bacterial genome into a closely related bacterium, Mycoplasma capricolum, coaxing it to "take this bacterial genome and boot it up" and generate their mutant strain, said linkurl:Sanjay Vashee,;http://www.jcvi.org/cms/about/bios/svashee/ a synthetic biologist at the institute and the corresponding author on the paper. The hurdle Vashee and his team had to overcome to achieve this feat involved bypassing the bacterial equivalent of an immune system -- essentially a collection of restriction enzymes. These enzymes, thought to have evolved to chew up the genomes of viruses infecting bacterial cells, were preventing the successful transplantation of the modified M. mycoides genome into wild-type M. capricolum. So the group developed two fixes, which together solved the problem: First, they inactivated M. capricolum's restriction enzymes. Then, they chemically modified their mutant M. mycoides genome where these enzymes typically cleave the genomes of intruders. Decades of research on yeast genetics have yielded the know-how to do extensive genomic manipulations in yeast, but that capability doesn't exist for other microorganisms. "There are so many organisms in nature that we cannot manipulate," said Vashee. "If we can extend this -- and put those genomes into yeast, to manipulate them there -- we've got a new technology that can bring genomics to a wide host of organisms." (Vashee noted that the current study was conducted in a natural Mycoplasma genome -- not the synthetic genome the group assembled last year.) Over the past several years, researchers have proposed a plethora of possibilities for using microorganisms to produce energy. "The challenge in the next few years will be [to see] who can actually convert these very cool ideas from a desk-top [experiment] to a large industrial process," said Collins. To make that happen, researchers will "need to change a lot in [their] organism, in a directed fashion," he explained. "These guys now open the possibility that you can do that relatively efficiently by just ripping out the genome, putting it in yeast, and putting it back -- or putting it into a new organism" which reproduces faster, for example. Vashee said the group is applying this technique to their long-standing interest in building a "minimal cell." By removing chunks of the genetic code of M. mycoides and M. genitalium, then transplanting these bare-bones genomes back into their own cytoplasm to check if they still function, the group hopes to "get at the question of what is life at its bare essentials," Vashee said. They also plan to begin fiddling with the genome of cyanobacteria -- a hot microorganism in biofuels research -- to increase the efficiency with which it produces energy. Cyanobacteria are more complex organisms, though, Vashee said, adding, "I think that will take a little more effort."
**__Related stories:__***linkurl:Future oil;http://www.the-scientist.com/article/display/55376/
[February 2009]*linkurl:Can bacteria rescue the oil industry?;http://www.the-scientist.com/2009/02/1/30/1/
[February 2009]*linkurl:Artificial life, a step closer;http://www.the-scientist.com/blog/display/54212/
[24th January 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Alla Katsnelson

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development